Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of (Dollar) 27 billion by 2029.
Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of (Dollar) 27 billion by 2029.